2015 RayStation Symposium in Australasia PROGRAMME ONLINE

Less than 3 weeks before the Inaugural RayStation Symposium in Australasia -  Saturday 10th of October 2015 at the Four Seasons Hotel in Sydney, Australia.

Hurry up and register, a limited number of rooms are available at a discounted rate at the Four Seasons Hotel!

For the programme please visit www.alphaxrt.com/RS2015.

Looking forward to see you there!

Read More

alphaXRT awarded 2014 International Distributor of the Year

At the recent Sun Nuclear Global Sales Training for distributors, Diana Mannering accepted the 2014 Distributor of the Year, Overall Performance award, presented to alphaXRT by Jeff Simon, CEO of Sun Nuclear and Bill Simon, President and Chief Science Officer of Sun Nuclear.

The award is "In recognition of outstanding dedication to Sales, Service and Customer Satisfaction”.

Diana Mannering (center) receives the 2014 Distributor of the Year, Overall Performance award presented by Jeff Simon (left) and Bill Simon (right).

Video demo: Fallback planning in RayStation with rayFallback

Watch this video to learn how rayFallback, RayStation's Fallback planning module, can help you create fallback plans for any modality or treatment technique. This will help you avoid any disruptions in your patients treatment and stress on staff when a machine is unavailable. Also it is a first step towards automated planning and can be alternatively use to evaluate plans.

Read More

VisionTree Optimal Care cloud platform available in Australia and New Zealand

VisionTree®, a leader in cloud-based, patient reported outcomes, patient engagement and multi-center research/registry solutions, is pleased to announce its distribution agreement with alphaXRT, a leading provider of radiotherapy software and equipment in Australasia. With the growing adoption and use of the VisionTree Optimal Care (VTOC) platform for patient-centered outcomes data management, patient engagement, interoperability and workflow solutions on a global level, this partnership with alphaXRT provides an end-to-end solution for oncology programs and the hospital enterprise, which keeps that patient at the center of outcomes and population health reporting.

The VTOC v4.1 platform is implemented at over 500 sites, including 8 of the top 10 U.S. News & World Report hospitals, and globally in 12+ countries comprising over 2M patient users as a patient portal including patient reported outcomes and providing a robust, clinical and multi-center research/registry solution. VTOC includes a library of over 200 patient reported outcomes measures (PROMs) assessments with template/timepoint manager across most all medical conditions, secure two-way messaging with form alerts, as well as interoperability (via HL7 interfaces) with most all hospital/oncology information systems and a suite of web service APIs to deliver a patient-centered outcomes data collection solutions in any clinical or research environment.

AlphaXRT is a leading distributor of software and equipment used in the treatment of cancer in Australasia and represents a wide range of respected international suppliers. The dedicated sales and support team at alphaXRT are highly experienced in the field of radiation therapy and serve all radiation therapy centres in Australia and New Zealand. Adding VTOC to its product suite provides alphaXRT customers the ability to collect and report patient and clinician outcomes data, including dosimetric data for longitudinal outcomes on a patient and aggregate level for clinical, research and registry purposes, as well as provide a market leading cancer survivorship program.

"It is important for us to provide innovative and valuable solutions to our radiotherapy customers that deliver a comprehensive approach to patient-centered care. The combination of alphaXRT products and the VTOC platform means users will have ability to connect disparate clinical systems and multiple centers to collect and report patient outcomes information at anytime and from virtually anywhere."

Richard Neale, alphaXRT Managing Director

"By starting at the point of initial patient intake with electronic patient reported forms, the VTOC platform helps sites deliver a completely paperless workflow and capture critical data points for quality healthcare decisions and operational efficiency. Disbribution of the VTOC platform by alphaXRT throughout Australia and New Zealand will allow physicians and staff real-time access and reporting of relevant data and alerts in their clinic and mobile environment, as well as provide the opportunity for global benchmarking and population health data management."

Martin Pellinat, CEO, VisionTree Software, Inc.

With over a decade in clinical use, VTOC has documented improvements in patient care and the clinical workflow; including up to 20% reduction in non-urgent phone calls, up to 30% improvement in missed appointments, over 30% increased patient satisfaction, and over 40% improved compliance for capturing longitudinal PROMs. VTOC helps providers in delivering risk-adjusted outcomes data, on an individual patient or an aggregate level, for an optimized delivery of quality and efficiency in on-going patient care.

The agreement between VisionTree and alphaXRT opens the possibility for thought leaders worldwide to use the VTOC platform to share best practice templates for patient and clinician reported outcomes measures driven by quality and value-based healthcare standards.

For more information, visit www.visiontree.com or email us at: accounts@alphaxrt.com

To learn more about VisionTree Optimal Care™, visit: VTOC Oncology

SOURCE: http://www.visiontree.com/news_healthcare/VisionTree-Announces-Distribution-Agreement-with-alphaXRT-in-Australia-and-New-Zealand/

Deformable Registration; the key to Adaptive Therapy

Learn about deformable registration and how it is essential for adaptive therapy. Will bring up common cases where deformable registration can be used, discuss related challenges as well as necessary features for success. You will see RayStation's approach to deformable registration with functionalities like structure propagation, dose deformation, treatment evaluation for delivered fractions and various QA options.

Read More